India on April 1 recorded 2,994 new COVID-19 infections, while the number of active cases increased to 16,354, according to Union health ministry data.
With the fresh infections, India's COVID-19 tally stands at 4.47 crore (4,47,18,781). The death toll climbed to 5,30,876 with nine deaths, the data updated at 8 am stated.
Two deaths each were reported from Delhi, Karnataka and Punjab, one from Gujarat, and two were reconciled by Kerala.
At 16,354, the active cases comprise 0.04 per cent of the total infections. The national COVID-19 recovery rate stands at 98.77 per cent, according to the health ministry website.
The daily positivity rate was recorded at 2.09 per cent and the weekly positivity at 2.03 per cent.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
The number of people who have recuperated from the disease surged to 4,41,71,551. The case fatality rate stands at 1.19 per cent.
According to the ministry's website, 220.66 crore doses of COVID-19 vaccine have been administered so far under the nationwide vaccination drive.